The first large-scale trial of an experimental Ebola vaccine has begun in Liberia.
Large-scale vaccine trial begins in Liberia
About 30,000 people are expected to be injected with the experimental vaccine starting from Monday, February 2.
Recommended articles
![Osun State College of Technology OSCOTECH [MySchoolGist]](data:image/svg+xml;charset=utf8,%3Csvg%20xmlns%3D'http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg'%20width%3D'100'%20height%3D'100'%20data-ring-placeholder%3D'1'%3E%3C%2Fsvg%3E "Osun State College of Technology OSCOTECH [MySchoolGist]")
About 30,000 people are expected to be injected with the drug starting from Monday, February 2.
The subjects, which include health workers and volunteers, will be administered with a small amount of the vaccine which carries safe genetic material of Ebola, tricking the human body into producing an immune response.
The trial is being conducted as part of a partnership between Liberia and the US.
ADVERTISEMENT
Liberian Vice President, Joseph Nyumah Boakai told The Associated Press that the vaccines are "very important for Liberia and for the world."
The vaccine was developed by British pharmaceutical giant, GlaxoSmithKline in conjunction with the U.S. National Institutes of Health.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
UNN to reduce unemployment among Nigerian graduates through mentoring
AGF calls for strong internal controls to curb financial mismanagement
Tariff has been hiked with no improvement - Abuja residents decry power outage
Emefiele's trial adjourned to June 24, key witness cross-examined
Former ECOWAS Court VP slams EFCC chairman's handling of Yahaya Bello case
Let’s drill 200k boreholes across the country — Obi begs wealthy Nigerians
Ondo 2024: Ex-governor's brother emerges gubernatorial candidate
UK varsity rolls out tuition, travel-free scholarship for Nigerian students
President Biden signs law to potentially ban TikTok if not sold
ADVERTISEMENT
